D
D.Western Therapeutics Institute Inc
TSE:4576
D.Western Therapeutics Institute Inc
TSE:4576
Price:
104
JPY
5.05%
Market Closed
Market Cap:
¥5.6B
Balance Sheet
Balance Sheet Decomposition
D.Western Therapeutics Institute Inc
D.Western Therapeutics Institute Inc
Balance Sheet Decomposition is not available for
D.Western Therapeutics Institute Inc
D.Western Therapeutics Institute Inc
Balance Sheet
D.Western Therapeutics Institute Inc
D.Western Therapeutics Institute Inc
Currency: JPY
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
33
|
189
|
614
|
493
|
382
|
1 373
|
943
|
620
|
424
|
1 647
|
1 447
|
1 747
|
2 292
|
2 133
|
1 584
|
1 541
|
2 308
|
1 934
|
2 335
|
1 867
|
1 126
|
1 710
|
|
| Cash Equivalents |
33
|
189
|
614
|
493
|
382
|
1 373
|
943
|
620
|
424
|
1 647
|
1 447
|
1 747
|
2 292
|
2 133
|
1 584
|
1 541
|
2 308
|
1 934
|
2 335
|
1 867
|
1 126
|
1 710
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
20
|
619
|
0
|
183
|
353
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
4
|
0
|
8
|
7
|
8
|
2
|
0
|
0
|
0
|
0
|
23
|
36
|
61
|
71
|
104
|
92
|
102
|
171
|
117
|
125
|
95
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
36
|
61
|
71
|
104
|
92
|
102
|
171
|
117
|
125
|
95
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
58
|
46
|
59
|
59
|
58
|
88
|
79
|
88
|
102
|
87
|
|
| Other Current Assets |
1
|
1
|
2
|
13
|
15
|
5
|
4
|
7
|
9
|
12
|
27
|
72
|
38
|
275
|
50
|
12
|
45
|
38
|
74
|
66
|
122
|
129
|
|
| Total Current Assets |
35
|
194
|
616
|
515
|
404
|
1 387
|
969
|
648
|
453
|
2 278
|
2 109
|
2 025
|
2 776
|
2 516
|
1 764
|
1 716
|
2 503
|
2 162
|
2 659
|
2 138
|
1 475
|
2 020
|
|
| PP&E Net |
16
|
5
|
10
|
27
|
28
|
16
|
12
|
8
|
6
|
5
|
6
|
5
|
25
|
15
|
5
|
3
|
5
|
5
|
10
|
10
|
11
|
9
|
|
| PP&E Gross |
16
|
5
|
10
|
27
|
28
|
16
|
12
|
8
|
6
|
5
|
6
|
5
|
25
|
15
|
5
|
3
|
5
|
5
|
10
|
10
|
11
|
9
|
|
| Accumulated Depreciation |
4
|
2
|
3
|
17
|
29
|
39
|
47
|
52
|
54
|
56
|
57
|
58
|
75
|
88
|
88
|
88
|
90
|
92
|
96
|
101
|
107
|
112
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
330
|
292
|
250
|
208
|
167
|
125
|
87
|
44
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
100
|
101
|
11
|
5
|
5
|
13
|
123
|
154
|
142
|
143
|
143
|
|
| Other Long-Term Assets |
2
|
6
|
10
|
10
|
13
|
10
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
5
|
7
|
7
|
8
|
7
|
9
|
3
|
4
|
5
|
|
| Total Assets |
53
N/A
|
205
+290%
|
636
+209%
|
551
-13%
|
447
-19%
|
1 412
+216%
|
991
-30%
|
666
-33%
|
468
-30%
|
2 292
+390%
|
2 136
-7%
|
2 140
+0%
|
2 913
+36%
|
2 877
-1%
|
2 074
-28%
|
1 981
-4%
|
2 738
+38%
|
2 463
-10%
|
2 956
+20%
|
2 373
-20%
|
1 669
-30%
|
2 169
+30%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
3
|
1
|
3
|
4
|
5
|
6
|
6
|
5
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
45
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
120
|
120
|
120
|
130
|
120
|
10
|
19
|
99
|
|
| Other Current Liabilities |
7
|
8
|
8
|
12
|
14
|
21
|
18
|
21
|
12
|
20
|
17
|
27
|
36
|
156
|
148
|
43
|
90
|
64
|
91
|
184
|
114
|
105
|
|
| Total Current Liabilities |
54
|
39
|
11
|
15
|
19
|
27
|
24
|
26
|
15
|
23
|
19
|
27
|
36
|
156
|
268
|
189
|
210
|
193
|
211
|
194
|
133
|
204
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
600
|
480
|
360
|
340
|
210
|
848
|
876
|
779
|
506
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
196
|
139
|
95
|
40
|
15
|
0
|
28
|
16
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
25
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
|
| Total Liabilities |
62
N/A
|
39
-36%
|
11
-73%
|
15
+47%
|
19
+24%
|
27
+40%
|
24
-11%
|
26
+11%
|
15
-42%
|
23
+49%
|
19
-14%
|
223
+1 047%
|
175
-22%
|
877
+402%
|
814
-7%
|
588
-28%
|
574
-2%
|
456
-21%
|
1 099
+141%
|
1 094
0%
|
936
-14%
|
734
-22%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
10
|
124
|
374
|
479
|
604
|
1 279
|
1 279
|
1 292
|
1 327
|
2 348
|
2 367
|
2 400
|
2 945
|
3 365
|
35
|
35
|
557
|
573
|
714
|
832
|
1 203
|
697
|
|
| Retained Earnings |
19
|
72
|
112
|
412
|
770
|
1 163
|
1 582
|
1 934
|
2 191
|
2 415
|
2 607
|
2 873
|
3 142
|
4 719
|
908
|
775
|
1 049
|
1 198
|
1 629
|
2 442
|
3 731
|
543
|
|
| Additional Paid In Capital |
0
|
114
|
364
|
469
|
594
|
1 269
|
1 269
|
1 282
|
1 317
|
2 338
|
2 357
|
2 390
|
2 935
|
3 355
|
2 133
|
2 133
|
2 656
|
2 631
|
2 772
|
2 890
|
3 262
|
1 281
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
166
N/A
|
625
+277%
|
536
-14%
|
428
-20%
|
1 386
+224%
|
967
-30%
|
639
-34%
|
452
-29%
|
2 269
+402%
|
2 116
-7%
|
1 917
-9%
|
2 738
+43%
|
2 001
-27%
|
1 260
-37%
|
1 393
+11%
|
2 164
+55%
|
2 007
-7%
|
1 857
-7%
|
1 280
-31%
|
734
-43%
|
1 435
+96%
|
|
| Total Liabilities & Equity |
53
N/A
|
205
+290%
|
636
+209%
|
551
-13%
|
447
-19%
|
1 412
+216%
|
991
-30%
|
666
-33%
|
468
-30%
|
2 292
+390%
|
2 136
-7%
|
2 140
+0%
|
2 913
+36%
|
2 877
-1%
|
2 074
-28%
|
1 981
-4%
|
2 738
+38%
|
2 463
-10%
|
2 956
+20%
|
2 373
-20%
|
1 669
-30%
|
2 169
+30%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
10
|
11
|
12
|
12
|
12
|
17
|
17
|
18
|
18
|
23
|
23
|
23
|
25
|
26
|
26
|
26
|
29
|
29
|
31
|
32
|
42
|
54
|
|
Switch to:
Switch to:
See Also
Discover More
